Kestra Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Kestra Advisory Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.06M	Sell	25,660 -403	-2%	-$54.5K	0.01%	957
2026 Q1	$3.33M	Buy	26,063 +6,073	+30%	+$758K	0.01%	1011
2025 Q4	$2.44M	Buy	19,990 +474	+2%	+$54.3K	0.01%	1108
2025 Q3	$1.96M	Sell	19,516 -2,717	-12%	-$245K	0.01%	1163
2025 Q2	$1.84M	Sell	22,233 -69	-0.3%	-$5.5K	0.01%	1126
2025 Q1	$1.81M	Sell	22,302 -3,539	-14%	-$316K	0.01%	1033
2024 Q4	$2.33M	Sell	25,841 -8,209	-24%	-$795K	0.01%	921
2024 Q3	$3.36M	Sell	34,050 -4,238	-11%	-$416K	0.02%	724
2024 Q2	$3.55M	Buy	38,288 +8,819	+30%	+$791K	0.02%	711
2024 Q1	$2.8M	Buy	29,469 +9,114	+45%	+$846K	0.02%	736
2023 Q4	$1.82M	Sell	20,355 -3,003	-13%	-$223K	0.01%	835
2023 Q3	$1.71M	Buy	23,358 +1,265	+6%	+$101K	0.02%	747
2023 Q2	$1.84M	Buy	22,093 +202	+0.9%	+$16.9K	0.02%	704
2023 Q1	$1.67M	Sell	21,891 -693	-3%	-$57.5K	0.02%	720
2022 Q4	$1.87M	Sell	22,584 -581	-3%	-$47K	0.02%	776
2022 Q3	$1.84M	Sell	23,165 -7,768	-25%	-$655K	0.02%	701
2022 Q2	$2.3M	Sell	30,933 -706	-2%	-$53K	0.02%	624
2022 Q1	$2.84M	Buy	31,639 +1,499	+5%	+$138K	0.03%	552
2021 Q4	$3.37M	Sell	30,140 -3,136	-9%	-$378K	0.03%	498
2021 Q3	$4.18M	Sell	33,276 -6,024	-15%	-$776K	0.04%	451
2021 Q2	$5.32M	Sell	39,300 -1,934	-5%	-$254K	0.06%	344
2021 Q1	$5.59M	Buy	41,234 +13,801	+50%	+$2.07M	0.07%	311
2020 Q4	$3.95M	Buy	27,433 +7,704	+39%	+$987K	0.05%	394
2020 Q3	$2.2M	Buy	+19,729	New	+$2.21M	0.04%	408

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Kestra Advisory Services's XBI Position: Q2 2026 in Review

Kestra Advisory Services reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.5% in Q2 2026, selling an estimated $54.5K and leaving 25,660 shares worth $4.06M. The position accounts for 0.01% of the portfolio, ranked #957.

Kestra Advisory Services first reported a position in XBI in Q3 2020 and has held it in 24 quarters since. The position peaked at $5.59M in Q1 2021. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Kestra Advisory Services held 25,660 shares of State Street SPDR S&P Biotech ETF worth $4.06M as of Q2 2026.
Kestra Advisory Services sold 403 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $54.5K.
State Street SPDR S&P Biotech ETF made up 0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #957 holding.
Kestra Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 24 quarters since.
Kestra Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $5.59M in Q1 2021.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.